Search

Search Results
Results 2821 - 2830 of 7070 for Alternative Medicine
  • News - 28 Dec 2007
    It's good news that we are living longer, but bad news that the longer we live, the better our odds of developing late-onset Alzheimer's disease.
  • News - 20 Dec 2007
    A University of South Florida fetal surgeon at Tampa General Hospital successfully treated in utero a rare but potentially devastating condition in which placental blood vessels block the birth canal...
  • News - 15 Nov 2007
    GlaxoSmithKline announced today that it is implementing changes to the US product label for Avandia(R) (rosiglitazone maleate), based on an extensive and thorough review by the FDA of myocardial...
  • News - 22 Oct 2007
    Watching comedy shows helped children tolerate pain for longer periods of time, suggesting that humorous distraction could be used in clinical settings to help children and adolescents better handle...
  • News - 9 Oct 2007
    New research shows that selective serotonin reuptake inhibitors (SSRIs), a group of drugs commonly used to treat depression, may double the risk of gastrointestinal bleeding, according to researchers...
  • News - 26 Sep 2007
    For years researchers in neurology have believed that people with Huntington's disease have more children than the general population because of behavioral changes associated with the disease that...
  • News - 14 Sep 2007
    Before a new treatment for a disease like cancer becomes available, physician-researchers must recruit hundreds or thousands of patients to participate in clinical research trials.
  • News - 12 Sep 2007
    An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the...
  • News - 22 Aug 2007
    Non-medicinal interventions are highly effective in preventing the behavioral and academic problems associated with Attention Deficit Hyperactivity Disorder (ADHD), according to a five-year study led...
  • News - 16 Aug 2007
    Researchers at the University of Pennsylvania School of Medicine have found that a commonly prescribed diabetes drug kills tumor cells that lack a key regulatory gene called p53.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.